Gene Symbol | HLA-A |
Entrez ID | 3105 |
Uniprot ID | P30443 |
Description | major histocompatibility complex, class I, A |
Chromosomal Location | chr6: 29,941,260-29,945,884 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I |
The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules. |
TAS |
BP |
GO:0002479 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules. |
TAS |
BP |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent |
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules. |
TAS |
BP |
GO:0016032 |
viral process |
A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
IEA |
BP |
GO:0019882 |
antigen processing and presentation |
The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. |
IBA |
BP |
GO:0050776 |
regulation of immune response |
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
TAS |
BP |
GO:0060333 |
interferon-gamma-mediated signaling pathway |
A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far. |
TAS |
BP |
GO:0060337 |
type I interferon signaling pathway |
A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
TAS |
CC |
GO:0000139 |
Golgi membrane |
The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
TAS |
CC |
GO:0005783 |
endoplasmic reticulum |
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
ISS |
CC |
GO:0005794 |
Golgi apparatus |
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
ISS |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
IBA|TAS |
CC |
GO:0009986 |
cell surface |
The external part of the cell wall and/or plasma membrane. |
ISS |
CC |
GO:0012507 |
ER to Golgi transport vesicle membrane |
The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi. |
TAS |
CC |
GO:0030670 |
phagocytic vesicle membrane |
The lipid bilayer surrounding a phagocytic vesicle. |
TAS |
CC |
GO:0031901 |
early endosome membrane |
The lipid bilayer surrounding an early endosome. |
TAS |
CC |
GO:0042612 |
MHC class I protein complex |
A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules. |
ISS |
CC |
GO:0071556 |
integral component of lumenal side of endoplasmic reticulum membrane |
The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the lumenal side of the membrane. |
TAS |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0030881 |
beta-2-microglobulin binding |
Interacting selectively and non-covalently with beta-2-microglobulin. |
IMP|ISS |
MF |
GO:0042605 |
peptide antigen binding |
Interacting selectively and non-covalently with an antigen peptide. |
IMP|ISS |
MF |
GO:0044822 |
poly(A) RNA binding |
Interacting non-covalently with a poly(A) RNA, a RNA molecule which has a tail of adenine bases. |
IDA |
Domain ID | Description |
---|---|
IPR001039 |
MHC class I alpha chain, alpha1 alpha2 domains |
IPR003006 |
Immunoglobulin/major histocompatibility complex, conserved site |
IPR003597 |
Immunoglobulin C1-set |
IPR007110 |
Immunoglobulin-like domain |
IPR010579 |
MHC class I, alpha chain, C-terminal |
IPR011161 |
MHC class I-like antigen recognition-like |
IPR011162 |
MHC classes I/II-like antigen recognition protein |
IPR013783 |
Immunoglobulin-like fold |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04144 |
Endocytosis |
KEGG |
hsa04145 |
Phagosome |
KEGG |
hsa04514 |
Cell adhesion molecules (CAMs) |
KEGG |
hsa04612 |
Antigen processing and presentation |
KEGG |
hsa04650 |
Natural killer cell mediated cytotoxicity |
KEGG |
hsa04940 |
Type I diabetes mellitus |
KEGG |
hsa05166 |
HTLV-I infection |
KEGG |
hsa05168 |
Herpes simplex infection |
KEGG |
hsa05169 |
Epstein-Barr virus infection |
KEGG |
hsa05203 |
Viral carcinogenesis |
KEGG |
hsa05320 |
Autoimmune thyroid disease |
KEGG |
hsa05330 |
Allograft rejection |
KEGG |
hsa05332 |
Graft-versus-host disease |
KEGG |
hsa05416 |
Viral myocarditis |
KEGG |
WP2328 |
Allograft Rejection |
WikiPathways |
WP183 |
Proteasome Degradation |
WikiPathways |
h_mhcPathway |
Antigen Processing and Presentation |
BioCarta |
h_ctlPathway |
CTL mediated immune response against target cells |
BioCarta |
h_nkcellsPathway |
Ras-Independent pathway in NK cell-mediated cytotoxicity |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0004352 |
Autistic Disorder |
C0017638 |
Glioma |
C0026764 |
Multiple Myeloma |
C0030491 |
Parapsoriasis |
C0038013 |
Ankylosing Spondylitis |
C0038325 |
Stevens-Johnson Syndrome |
C0040034 |
Thrombocytopenia |
C0860207 |
Drug-Induced Liver Injury |
Database Name |
---|
DisGeNET |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
25393639 |
Ambekar et al. |
2014 |
Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
CANX |
821 |
P27824 |
0.52 |
DEK |
7913 |
P35659 |
0.55 |
FLNB |
2317 |
O75369 |
0.63 |
FLNC |
2318 |
Q14315 |
0.63 |
MEOX2 |
4223 |
P50222 |
0.63 |
PSMD2 |
5708 |
Q13200 |
0.63 |
STAT3 |
6774 |
P40763 |
0.63 |
BAG6 |
7917 |
P46379 |
0.63 |
COPG1 |
22820 |
Q9Y678 |
0.63 |
UBE2J1 |
51465 |
Q9Y385 |
0.63 |
SYVN1 |
84447 |
Q86TM6 |
0.63 |
HLA-A |
3105 |
P30443 |
0.66 |
COPB1 |
1315 |
P53618 |
0.72 |
UGGT1 |
56886 |
Q9NYU2 |
0.72 |
B2M |
567 |
P61769 |
0.82 |
TCRB |
6957 |
P04435 |
0.89 |
CALR |
811 |
P27797 |
0.49 |
SCLT1 |
132320 |
Q96NL6 |
0.49 |
TMEM17 |
200728 |
Q86X19 |
0.49 |
APLP2 |
334 |
Q06481 |
0.52 |
ERBB2 |
2064 |
P04626 |
0.52 |
LMAN1 |
3998 |
P49257 |
0.52 |
PRKAR1A |
5573 |
P10644 |
0.52 |
PRKCA |
5578 |
P17252 |
0.55 |
SRC |
6714 |
P12931 |
0.62 |
LILRB2 |
10288 |
Q8N423 |
0.62 |
AKT2 |
208 |
P31751 |
0.63 |
CD1B |
910 |
P29016 |
0.63 |
CD3E |
916 |
P07766 |
0.63 |
EGFR |
1956 |
P00533 |
0.63 |
ERBB3 |
2065 |
P21860 |
0.63 |
GABRE |
2564 |
P78334 |
0.63 |
GNAS |
2778 |
P84996 |
0.63 |
HLA-A |
3105 |
P30457 |
0.63 |
HLA-B |
3106 |
P01889 |
0.63 |
HLA-C |
3107 |
P30499 |
0.63 |
HLA-DPA1 |
3113 |
P20036 |
0.63 |
HLA-DQA1 |
3117 |
P01909 |
0.63 |
HLA-DRB5 |
3127 |
Q30154 |
0.63 |
HLA-E |
3133 |
P13747 |
0.63 |
IFI16 |
3428 |
Q16666 |
0.63 |
ILK |
3611 |
Q13418 |
0.63 |
IRAK1 |
3654 |
P51617 |
0.63 |
ATXN3 |
4287 |
P54252 |
0.63 |
NEDD8 |
4738 |
Q15843 |
0.63 |
NTRK1 |
4914 |
P04629 |
0.63 |
PRG2 |
5553 |
P13727 |
0.63 |
PTCH1 |
5727 |
Q13635 |
0.63 |
RPS6KB2 |
6199 |
Q9UBS0 |
0.63 |
TAP2 |
6891 |
Q03519 |
0.63 |
SUMO1 |
7341 |
P63165 |
0.63 |
VCP |
7415 |
P55072 |
0.63 |
HERC2 |
8924 |
O95714 |
0.63 |
ITM2B |
9445 |
Q9Y287 |
0.63 |
HS2ST1 |
9653 |
Q7LGA3 |
0.63 |
CUL7 |
9820 |
Q14999 |
0.63 |
ZDHHC17 |
23390 |
Q8IUH5 |
0.63 |
ATP1B4 |
23439 |
Q9UN42 |
0.63 |
TRAM1 |
23471 |
Q15629 |
0.63 |
SEC61A1 |
29927 |
P61619 |
0.63 |
SCARA3 |
51435 |
Q6AZY7 |
0.63 |
IL20RB |
53833 |
Q6UXL0 |
0.63 |
PCDHB15 |
56121 |
Q9Y5E8 |
0.63 |
MMS19 |
64210 |
Q96T76 |
0.63 |
CCDC8 |
83987 |
Q9H0W5 |
0.63 |
ZACN |
353174 |
Q401N2 |
0.63 |
PDIA3 |
2923 |
P30101 |
0.66 |
ATM |
472 |
Q13315 |
0.72 |
TMEM129 |
92305 |
A0AVI4 |
0.73 |
MAGEA1 |
4100 |
P43355 |
0.75 |
TAP1 |
6890 |
Q03518 |
0.82 |
DERL1 |
79139 |
Q9BUN8 |
0.83 |
TAPBP |
6892 |
O15533 |
0.84 |
BCAP31 |
10134 |
P51572 |
0.85 |
KIR3DL2 |
3812 |
P43630 |
0.86 |
TRA |
6955 |
N/A |
0.88 |
LILRB1 |
10859 |
Q8NHL6 |
0.88 |
CD8A |
925 |
P01732 |
0.89 |
MAGEA4 |
4103 |
P43358 |
0.89 |